ciprofloxacin has been researched along with Diffuse Parenchymal Lung Disease in 5 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Similar effects were observed in SSc-interstitial lung disease (ILD) lung fibroblasts." | 1.38 | Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1. ( Bujor, AM; Christmann, RB; Haines, P; Junie, M; Lafyatis, R; Padilla, C; Sampaio-Barros, PD; Trojanowska, M, 2012) |
| "Ciprofloxacin can induce interstitial pneumonitis with acute respiratory failure." | 1.32 | Ciprofloxacin-induced acute interstitial pneumonitis. ( Bubendorf, L; Leuppi, JD; Oberholzer, M; Steiger, D; Tamm, M, 2004) |
| "Rhabdomyolysis and acute renal failure were successfully treated by transfusion, diuretic therapy, and glucocorticoid therapy." | 1.32 | [Surviving case of Legionella pneumonia showing a high level of serum KL-6 and complicated with rhabdomyolysis]. ( Kawai, A; Nakajima, H; Nakajima, S; Sawaguchi, H; Touda, Y, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J | 1 |
| Meng, J | 1 |
| Cao, L | 1 |
| Li, Y | 1 |
| Deng, P | 1 |
| Pan, P | 1 |
| Hu, C | 1 |
| Yang, H | 1 |
| Hantz, S | 1 |
| Garnier, F | 1 |
| Peuchant, O | 1 |
| Menetrey, C | 1 |
| Charron, A | 1 |
| Ploy, MC | 1 |
| Bébéar, C | 1 |
| Pereyre, S | 1 |
| Bujor, AM | 1 |
| Haines, P | 1 |
| Padilla, C | 1 |
| Christmann, RB | 1 |
| Junie, M | 1 |
| Sampaio-Barros, PD | 1 |
| Lafyatis, R | 1 |
| Trojanowska, M | 1 |
| Steiger, D | 1 |
| Bubendorf, L | 1 |
| Oberholzer, M | 1 |
| Tamm, M | 1 |
| Leuppi, JD | 1 |
| Kawai, A | 1 |
| Nakajima, H | 1 |
| Sawaguchi, H | 1 |
| Touda, Y | 1 |
| Nakajima, S | 1 |
5 other studies available for ciprofloxacin and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Synthesis and investigations of ciprofloxacin loaded engineered selenium lipid nanocarriers for effective drug delivery system for preventing lung infections of interstitial lung disease.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Bacterial Infections; Catalase; Ciprofloxacin; Drug Ca | 2019 |
Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Lung Diseases, Inte | 2012 |
Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1.
Topics: Cartilage Oligomeric Matrix Protein; Case-Control Studies; Cells, Cultured; Ciprofloxacin; Collagen | 2012 |
Ciprofloxacin-induced acute interstitial pneumonitis.
Topics: Acute Disease; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Lung Diseases, Interstiti | 2004 |
[Surviving case of Legionella pneumonia showing a high level of serum KL-6 and complicated with rhabdomyolysis].
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Antibodies, Bacterial; Antigens; Antigens, Bacteri | 2004 |